| 6016 |
Centers for Disease Control and Prevention |
Html |
en |
Arsenic (inorganic compounds, as As) - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6053 |
Centers for Disease Control and Prevention |
Html |
en |
Isophorone diisocyanate - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6435 |
Centers for Disease Control and Prevention |
Html |
en |
Science Clips - Monday, December 05, 2011 |
null |
| Science Clips | 0.900887 |
| current awareness | 0.224816 |
| informational purposes | 0.217279 |
| Chief Science Officer | 0.349834 |
| public health literature | 0.324435 |
| SFX server | 0.248505 |
| B. Thacker CDC | 0.765127 |
| SFX window | 0.247333 |
| full-text link | 0.231568 |
| original authors | 0.220784 |
| DHHS | 0.252412 |
|
| non-CDC Websites | 0.221534 |
| original sources | 0.227067 |
| Disease Control | 0.223073 |
| CDC Science Clips | 0.693763 |
| public domain | 0.231961 |
| CDC licensed materials | 0.519194 |
| news sources | 0.21852 |
| Stephen B. Thacker | 0.592037 |
| factual accuracy | 0.226842 |
| Thacker CDC Library | 0.756675 |
|
CLICK HERE |
| 6800 |
Centers for Disease Control and Prevention |
Html |
en |
Swine-Origin Influenza A (H3N2) Virus Infection in Two Children --- Indiana and Pennsylvania, July--August 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| influenza diagnostic test | 0.387343 |
| swine influenza virus | 0.492118 |
| Influenza Virus Surveillance | 0.417911 |
| influenza genomic sequences | 0.375913 |
| febrile respiratory illness | 0.314073 |
| Influenza Div | 0.355412 |
| novel influenza | 0.353787 |
| swine influenza | 0.496309 |
| human influenza viruses | 0.46182 |
| Non-human influenza virus | 0.407974 |
| additional influenza | 0.362392 |
| Influenza Virus Team | 0.412918 |
| swine-origin influenza viruses | 0.430744 |
| CDC-supported influenza surveillance | 0.435009 |
| influenza virus segments | 0.417764 |
| influenza virus infection | 0.481272 |
| influenza antiviral medications | 0.438566 |
| influenza testing capabilities | 0.370719 |
| avian-origin influenza | 0.388899 |
| swine-origin influenza virus | 0.481109 |
| suspect swine-origin influenza | 0.40687 |
| influenza illness | 0.352448 |
| public health | 0.351174 |
|
| influenza A virus | 0.414581 |
| origin influenza viruses | 0.449526 |
| animal influenza viruses | 0.403945 |
| seasonal influenza virus | 0.409712 |
| influenza vaccine | 0.400782 |
| non-human influenza viruses | 0.404358 |
| influenza activity | 0.36392 |
| nasopharyngeal swab | 0.297507 |
| health laboratories | 0.304639 |
| swine-origin influenza | 0.950464 |
| influenza virus infections | 0.525019 |
| H3N2 influenza viruses | 0.426061 |
| human infections | 0.39433 |
| routine CDC-supported influenza | 0.436657 |
| Influenza Division | 0.354453 |
| influenza viruses | 0.55575 |
| state public health | 0.350335 |
| influenza virus | 0.625228 |
| public health laboratories | 0.302328 |
| influenza a viruses | 0.4303 |
| public health laboratory | 0.323644 |
| human infection | 0.30732 |
|
CLICK HERE |
| 7060 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Iraq |
null |
| Content source | 0.422709 |
| HHS | 0.297574 |
| list Skip | 0.74332 |
| endorsement | 0.291872 |
| CDC | 0.271556 |
| non-federal site | 0.4688 |
|
| Notice | 0.270187 |
| sponsors | 0.241885 |
| page options Skip | 0.947337 |
| information | 0.241652 |
| employees | 0.242118 |
|
CLICK HERE |
| 8371 |
Centers for Disease Control and Prevention |
Html |
en |
Prevention and Control of Meningococcal Disease |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| meningococcal disease epidemiology | 0.565285 |
| meningococcal capsular polysaccharide | 0.554336 |
| quadrivalent meningococcal polysaccharide-protein | 0.554131 |
| bivalent meningococcal polysaccharide | 0.576311 |
| meningococcal infection | 0.553436 |
| meningococcal vaccination | 0.677619 |
| pneumococcal conjugate vaccine | 0.517705 |
| adolescents | 0.523377 |
| meningococcal vaccine recommendations | 0.607912 |
| meningococcal polysaccharide-protein conjugate | 0.595172 |
| vaccine effectiveness | 0.585468 |
| meningococcal disease | 0.937972 |
| persons | 0.62914 |
| meningococcal capsular polysaccharides | 0.535863 |
| quadrivalent meningococcal polysaccharide | 0.633412 |
| dose | 0.551892 |
| infant meningococcal vaccine | 0.593933 |
| booster dose | 0.537001 |
| meningococcal polysaccharide vaccines | 0.565413 |
| meningococcal monovalent | 0.520454 |
| single dose | 0.545757 |
| Meningococcal Vaccines Work | 0.564097 |
| meningococcal vaccine | 0.691059 |
| invasive meningococcal disease | 0.56548 |
|
| United States | 0.747402 |
| meningococcal outbreaks | 0.526384 |
| N. meningitidis | 0.593056 |
| pathogenic meningococcal strain | 0.530877 |
| meningococcal vaccines | 0.680919 |
| meningococcal C conjugate | 0.525654 |
| U.S.-licensed meningococcal vaccine | 0.583447 |
| bactericidal antibody | 0.526257 |
| meningococcal disease peaks | 0.561423 |
| meningococcal conjugate vaccine | 0.80662 |
| meningococcal vaccine-naУÐ?ve subjects | 0.523413 |
| quadrivalent meningococcal conjugate | 0.572717 |
| meningococcal conjugate vaccination | 0.58166 |
| serogroup-specific meningococcal disease | 0.555591 |
| titers т‰Ѕ1 | 0.520059 |
| meningococcal conjugate vaccines | 0.66122 |
| unpublished data | 0.550618 |
| United Kingdom | 0.522749 |
| MenACWY conjugate vaccine | 0.512449 |
| adverse events | 0.558981 |
| MenACWY-D | 0.548119 |
| meningococcal serogroup | 0.549283 |
| meningococcal serogroups | 0.610455 |
| Meningococcal vaccination coverage | 0.548763 |
|
CLICK HERE |
| 9763 |
Centers for Disease Control and Prevention |
Html |
en |
Comorbidity in Adults with Epilepsy - United States,2010 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| epilepsy | 0.962708 |
| Figure). | 0.573331 |
| common medical comorbidities | 0.385936 |
| disease self-management programs | 0.454077 |
| medical comorbidities | 0.415617 |
| adults | 0.652287 |
| especially active epilepsy | 0.650913 |
| Human Services | 0.379647 |
| nonpsychiatric comorbidities | 0.369469 |
| National Health Interview | 0.468925 |
| health-care providers | 0.416783 |
| NHIS Sample Adult | 0.414474 |
| mental health disorder | 0.363745 |
| active epilepsy | 0.821815 |
| community epilepsy groups | 0.583385 |
| multiple chronic conditions | 0.404519 |
| U.S. Department | 0.379751 |
| disorders | 0.382735 |
| Epilepsy Foundation | 0.632181 |
| heart disease | 0.444906 |
| non-institutionalized U.S. population | 0.366926 |
| health promotion resources | 0.419644 |
| epilepsy specialist | 0.568336 |
| epilepsy management | 0.614949 |
|
| peptic ulcer disease | 0.367582 |
| sample adult component | 0.415011 |
| epilepsy groups | 0.662982 |
| chronic disease self-management | 0.45411 |
| risk factors | 0.382994 |
| epilepsy manage | 0.567036 |
| self-reported heart disease | 0.365044 |
| epilepsy incidence | 0.558474 |
| response rate | 0.380844 |
| U.S. adults | 0.40043 |
| epilepsy providers | 0.59479 |
| Health Interview Survey | 0.468247 |
| Chronic Disease Prevention | 0.371339 |
| liver condition | 0.387517 |
| local Epilepsy Foundation | 0.58199 |
| epilepsy status | 0.61472 |
| epilepsy prevalence | 0.573207 |
| high blood pressure | 0.40687 |
| inactive epilepsy | 0.697418 |
| Table). | 0.58765 |
| coronary heart disease | 0.394515 |
| representative U.S. sample | 0.369819 |
| public health agencies | 0.456091 |
|
CLICK HERE |
| 11330 |
Centers for Disease Control and Prevention |
Html |
en |
Program Evaluation |
This page provides tools and resources for researching and evaluating health literacy practice. |
| CDC’s Framework | 0.445324 |
| teach-back method | 0.414339 |
| public health effectiveness | 0.53156 |
| communication data | 0.423602 |
| type | 0.322904 |
| patient knowledge | 0.41414 |
| outcomes | 0.327168 |
| Proportion | 0.326202 |
| Example | 0.461456 |
| context | 0.349453 |
| clinicians | 0.322138 |
| communication | 0.528849 |
| results | 0.327362 |
| patient-centered measures | 0.468602 |
| area | 0.323066 |
| data sources | 0.412308 |
| level | 0.322891 |
| judgments | 0.327862 |
| healthcare team members | 0.511448 |
| available evidence | 0.43071 |
| community | 0.321003 |
| standards | 0.346463 |
| provider module | 0.417828 |
| Roadmap | 0.326833 |
| health literacy | 0.943504 |
|
| Goals | 0.321577 |
| lessons | 0.322315 |
| health literacy measures | 0.820322 |
| strong evaluation approach | 0.541619 |
| aspects | 0.323105 |
| description | 0.32528 |
| program performance | 0.525875 |
| specific health literacy | 0.560078 |
| health literacy programs | 0.569355 |
| inquiry | 0.32164 |
| systems | 0.321345 |
| value | 0.342476 |
| program efforts | 0.436318 |
| types | 0.321358 |
| strategies | 0.321564 |
| patient questions | 0.408752 |
| patient contact | 0.415584 |
| possible sources | 0.439496 |
| activities | 0.344799 |
| organization | 0.322059 |
| elements | 0.321597 |
| communication measures | 0.465511 |
| care plan | 0.416728 |
| evaluation process | 0.443364 |
|
CLICK HERE |
| 12326 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Spatial Analysis and Correlatesof County-Level Diabetes Prevalence, 2009-2010 - CDC |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| Diabetes Interactive Atlas | 0.517362 |
| percentage neighborhood food | 0.504312 |
| public health researchers | 0.489983 |
| percentage obese | 0.499993 |
| GWR software | 0.485121 |
| population density | 0.494723 |
| Disease Control | 0.514955 |
| percentage | 0.630817 |
| local GWR model | 0.517623 |
| global OLS model | 0.529462 |
| obesity prevalence | 0.50282 |
| county-level diabetes prevalence | 0.754762 |
| higher diabetes prevalence | 0.566481 |
| lower diabetes prevalence | 0.567594 |
| percentage living | 0.540882 |
| global OLS regression | 0.496595 |
| high diabetes prevalence | 0.619196 |
| diabetes studies | 0.4892 |
| common diabetes correlates | 0.528986 |
| OLS regression | 0.513354 |
| GWR models | 0.510022 |
| counties | 0.509711 |
| diabetes prevention programs | 0.508053 |
| percentage nonwhite population | 0.610803 |
| federal poverty level | 0.648793 |
|
| percentage hispanic population | 0.567677 |
| United States | 0.708987 |
| county level | 0.538853 |
| geographically weighted regression | 0.622207 |
| food deserts | 0.488358 |
| OLS regression models | 0.498391 |
| diabetes prevalence | 0.960316 |
| estimated percentage | 0.488665 |
| public health | 0.616463 |
| spatial variation | 0.499261 |
| variables | 0.484417 |
| GWR model | 0.637395 |
| basic OLS model | 0.496216 |
| American Community Survey | 0.511743 |
| low diabetes prevalence | 0.571424 |
| spatial autocorrelation | 0.5231 |
| public health programs | 0.493386 |
| spatial prevalence | 0.53735 |
| percentage population | 0.492805 |
| dependent variable | 0.492172 |
| Diabetes Translation Research | 0.500985 |
| OLS model | 0.65576 |
| American Diabetes Association | 0.504379 |
| physical inactivity | 0.605242 |
|
CLICK HERE |
| 12439 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Social Media in CommunicatingHealth Information: An Analysis of Facebook Groups Related toHypertension - CDC |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange on the very latest in chronic disease prevention, research findings, public health interventions, and the exploration of new theories and concepts.
|
| open Facebook groups | 0.479423 |
| health professional groups | 0.362616 |
| stepwise logistic regression | 0.413603 |
| Online support groups | 0.368024 |
| disease experience-sharing groups | 0.355353 |
| main objective | 0.377848 |
| Facebook group members | 0.419862 |
| social network site | 0.356807 |
| recent wall post | 0.594833 |
| hypertension awareness | 0.411716 |
| idiopathic pulmonary hypertension | 0.358325 |
| analyzed Facebook groups | 0.438854 |
| Facebook community | 0.424811 |
| Facebook groups | 0.906362 |
| hypertension-related open Facebook | 0.412391 |
| Facebook search box | 0.426273 |
| hypertension-related groups | 0.366919 |
| study | 0.389134 |
| diabetes-related Facebook groups | 0.433505 |
| experience-sharing groups | 0.356857 |
| cancer-related Facebook groups | 0.447649 |
| English hypertension-related Facebook | 0.410311 |
| top-displayed recent post | 0.354433 |
| awareness-creating groups | 0.356912 |
|
| total number | 0.355747 |
| Facebook pages | 0.42829 |
| Singapore Hypertension Club | 0.35986 |
| hypertension groups | 0.388664 |
| social media | 0.411078 |
| Facebook feature | 0.409756 |
| health professionals groups | 0.365368 |
| pulmonary arterial hypertension | 0.358384 |
| community hypertension programs | 0.358859 |
| Facebook account | 0.407862 |
| breast cancer-related Facebook | 0.423918 |
| product promotion groups | 0.358212 |
| health | 0.374615 |
| support groups | 0.396597 |
| Facebook users | 0.420847 |
| hypertension-related Facebook groups | 0.710536 |
| high blood pressure | 0.487724 |
| Facebook group walls | 0.418745 |
| social media sites | 0.398764 |
| Hypertension Support Group | 0.37728 |
| recent wall posts | 0.422689 |
| top-displayed recent wall | 0.405482 |
| open groups | 0.363268 |
| group size | 0.35662 |
|
CLICK HERE |